MedTrace Logo

ICG-NIR Guided Lymph Node Dissection in Gastric Cancer

NCT04056260 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 219

Last updated 2020-03-20

No results posted yet for this study

Summary

As the survival rate of patients with gastric cancer has increased, there has been a growing interest in interventions that improve postoperative quality of life. Therefore minimally invasive surgery or endoscopic resection has been performed much more frequently. However, adequate lymph node dissection is important as well. The aim of the study is to identify the feasibility of indocyanine green - near infra-red (ICG-NIR) guided sentinel lymph node dissection for the treatment of gastric cancer.

Conditions

  • Stomach Neoplasm

Interventions

PROCEDURE

ICG-NIR guided surgery

ICG 0.5mg/ml x 0.5ml x 4 sites injection through intra-operative endoscopy

Sponsors & Collaborators

  • Ho Seok Seo

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-20
Primary Completion
2020-08-31
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04056260 on ClinicalTrials.gov